Quantcast

Latest Oncology Stories

2014-06-17 13:07:52

Walter and Eliza Hall Institute of Medical Research Melbourne researchers have shown a type of leukaemia can be successfully ‘reversed’ by coaxing the cancer cells back into normal development. The discovery was made using a model of B-progenitor acute lymphoblastic leukaemia (B-ALL), the most common cancer affecting children. Researchers from the Walter and Eliza Hall Institute showed that switching off a gene called Pax5 could cause cancer in a model of B-ALL, while restoring...

2014-06-17 08:29:08

SAN DIEGO, June 17, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) announced that mocetinostat, the company's spectrum selective HDAC inhibitor, has been granted Orphan Drug Designation by the U.S. Food & Drug Administration as a treatment for myelodysplastic syndrome (MDS). Mocetinostat is being developed in Phase 2 clinical studies in combination with Vidaza as a treatment for intermediate and high-risk MDS, as well as a single agent treatment in patients with...

2014-06-17 08:29:05

Side-By-Side Genomic Analysis of Patients' Tumor and TumorGraft Mouse Avatars Before and After Treatment Also to be Conducted NEW YORK and HACKENSACK, N.J., June 17, 2014 /PRNewswire/ -- Icahn School of Medicine at Mount Sinai and Champions Oncology (OTC: CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced the initiation of a clinical trial evaluating the use of Champions...

2014-06-17 08:28:45

A unique jewelry collection supporting cancer survivors by Charles & Colvard® NEW YORK, June 17, 2014 /PRNewswire/ -- The Survivor Collection(TM) is a story of celebration. Inspired by the true story of two special friends, one battling cancer the other supporting and championing her friend through her struggle, and the search for something special to symbolize the brilliant promise of the future ahead. Trying to find a piece of jewelry to commemorate her friend's long journey and...

2014-06-17 08:28:31

Companies expect to commence first-in-human studies of Trx-1 in ovarian cancer in 1H15 BOSTON, June 17, 2014 /PRNewswire/ -- Australian oncology drug development company Novogen Limited [ASX:NRT; NASDAQ:NVGN] and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity. Based on the...

2014-06-17 04:21:42

Proof-of-Concept Trial Targets DNA Repair in Bile Duct Cancers SAN DIEGO and NEW TAIPEI CITY, Taiwan, June 17, 2014 /PRNewswire-iReach/ -- Senhwa Biosciences, Inc. announced today that the Company has initiated a randomized Phase 1b/2 Trial of CX-4945 in combination with gemcitabine and cisplatin for the frontline treatment of patients with bile duct cancers (cholangiocarcinoma). This Proof-of-Concept trial will study the use of CX-4945, a small molecule CK2 inhibitor, to suppress...

2014-06-17 04:21:35

Expanded License Includes New Product Candidates for Cancer, Infectious Diseases and Novel Immune Activators BLUE BELL, Pa., June 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) has expanded its existing license agreement with the University of Pennsylvania, adding exclusive worldwide rights to technology and intellectual property for novel synthetic therapies against cancer, infectious diseases and new immune activators. Inovio has an ongoing collaborative research...

2014-06-16 23:12:58

This week the Mesothelioma Victims Center tackles a side to mesothelioma never previously discussed by sharing a recent ACS article titled, “Nearing the End of Life.” The group is urging family members of a diagnosed victim of mesothelioma to read the article and then call them at 866-714-6466 not only for instant access to the nation's best mesothelioma compensation attorneys, but as importantly for information on how a family should deal with this rare, and lethal form of cancer....

2014-06-16 23:07:52

Tanning and sun exposure increases risk, but early detection is almost 100% effective. (PRWEB) June 16, 2014 We all enjoy having fun in the great outdoors. Whether someone is hiking, swimming horseback riding, or just having a picnic, the lure of a sunny day is hard to resist. Doctors have been telling people for years to wear sunscreen when they go outdoors, but the honest truth is that few people listen. The reason for this concern is of the lurking danger of melanoma, which is the most...

2014-06-16 23:01:53

Leaders will share best methods for addressing survivors’ needs. Austin, Texas (PRWEB) June 16, 2014 The LIVESTRONG Foundation is hosting its Survivorship Centers of Excellence Network as they present the LIVESTRONG Essential Elements of Survivorship Care to some of the leading providers of cancer care programs from throughout the U.S. in advance of this week’s 7th Biennial Cancer Survivorship Research Conference in Atlanta. Directors from the seven LIVESTRONG Survivorship Centers of...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related